Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.
Orca Bio has raised $250.0M in total funding. The most recent round was Series F. The last funding was announced in January 2026.
Orca Bio's investors include Lightspeed Venture Partners, 8VC, Felicis, Mubadala, DCVC Bio.
Orca Bio is headquartered in Menlo Park, United States.
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.
Orca Bio is at the Series F stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orca Bio — Funding & Investors." VCBacked, January 9, 2026, https://www.vcbacked.co/company/orca-bio. Accessed October 17, 2026.
VCBacked. (2026). Orca Bio — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/orca-bio
{{cite web |title=Orca Bio — Funding & Investors |url=https://www.vcbacked.co/company/orca-bio |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated